What tech stack does Adaptive Biotechnologies use?
Adaptive Biotechnologies's stack is detected from public sources such as engineering signals, job postings, product documentation, BuiltWith-style web observations, and enterprise-tool references. Treat it as directional, not a complete CMDB.
- Frontend
- Python
- Backend
- Python
- Cloud
- AWS
- Data
- Snowflake
- Critical path
- clonoSEQ
- GTM
- Salesforce
Adaptive Biotechnologies detected technologies
Detected technologies for Adaptive Biotechnologies include application, infrastructure, data, and go-to-market systems.
- Python· Application
- R· Application
- AWS· Application
- Kubernetes· Infrastructure
- Nextflow· Infrastructure
- LIMS· Infrastructure
- Snowflake· Data
- Databricks· Data
- Tableau· Data
- Salesforce· GTM or device
- Bioinformatics pipelines· GTM or device
What does Adaptive Biotechnologies use on the backend and infrastructure?
The public signal points to Python, R, AWS, Kubernetes, Nextflow, LIMS among the application and infrastructure layers. In regulated healthcare and life-science environments, backend architecture must support reliability, auditability, privacy, security, and data quality.
Treat the stack as directional. Confirm exact systems during discovery, especially when pitching platform, security, data, interoperability, or developer-productivity tools.
What does Adaptive Biotechnologies use on the frontend, data, or GTM tooling?
Detected or likely public signals include Snowflake, Databricks, Tableau, Salesforce, Bioinformatics pipelines. These layers matter because many buying motions require CRM, analytics, workflow, identity, and data integrations.
A strong technical discovery path asks which system owns the workflow, which team owns the data, and how regulated data moves between customer-facing and operational systems.
What Adaptive Biotechnologies's stack means if you sell to them
The integration angle should be specific: connect to existing data warehouses, CRMs, cloud environments, EHR or lab systems, analytics layers, or identity and security controls. Replacement pitches need stronger proof than augmentation pitches.
Because Adaptive Biotechnologies is a public healthcare or life-science company, security review, privacy review, compliance documentation, and implementation ownership will shape the deal as much as feature fit.
As of June 2026.Sources:Adaptive websiteAdaptive Q1 2026 results
Adaptive Biotechnologies — frequently asked questions
